Choosing the Right Stocks for LEAPS

LEAPS aren't for every stock. Adding leverage and a ticking clock to a mediocre business is a recipe for loss. The companies you choose must be rock-solid, predictable, and trading below intrinsic value with a clear path to re-rating. This isn't about chasing the highest premium or the biggest discount. It's about finding wonderful companies where time and valuation work in your favor.

TL;DR

• Quality first: Only use LEAPS on companies with durable competitive advantages and strong balance sheets
• Predictable earnings: Avoid cyclical or turnaround stories where timing is uncertain
• Clear undervaluation: The stock should trade 20-30% below your calculated intrinsic value
• Visible catalyst: Look for near-term events that could drive re-rating within your LEAPS timeframe
• Liquid options: Choose stocks with tight bid-ask spreads and decent open interest to avoid overpaying

Why Quality Matters More with LEAPS

When you own stock, you have time on your side. If you pick a mediocre company, you can hold through cycles and hope management improves. Not ideal, but survivable.

With LEAPS, you don't have that luxury. Your contract expires in 12 to 24 months. If the company stumbles, cuts guidance, or gets caught in an industry downturn, your option can lose value fast. You can't "wait it out" like you can with shares.

This is why LEAPS demand quality. You're leveraging capital and betting on timing. The underlying business must be so strong that even if your timing is slightly off, the fundamentals hold up and the stock doesn't crater.

Think of it this way: you wouldn't use margin to buy a risky turnaround. Same logic applies to LEAPS. Leverage belongs only on the safest ideas.

For a deeper dive on what makes a company "wonderful," read identifying wonderful companies.

The Checklist for LEAPS-Worthy Stocks

Not every undervalued stock is a good LEAPS candidate. Here's what to look for:

1. Economic moat
The company must have a sustainable competitive advantage: brand power, network effects, cost advantages, or regulatory protection. Without a moat, competitors can erode margins and slow growth. LEAPS require businesses that can hold their ground.

Examples: Coca-Cola's brand, Visa's network, Costco's scale. These advantages don't disappear in 18 months.

2. Predictable earnings and cash flow
You need visibility into future earnings. Companies with lumpy revenue, project-based income, or heavy exposure to commodity prices are risky for LEAPS. One bad quarter can tank your option value faster than the stock price.

Look for businesses with recurring revenue, subscription models, or stable demand across cycles. Boring is beautiful when you're on a clock.

3. Strong balance sheet
Low debt, positive free cash flow, and ample liquidity. If the company has too much debt or weak cash generation, a downturn can force cuts or dilution. Your LEAPS won't survive that.

Check the debt and leverage ratios before committing. A company drowning in debt is not a LEAPS candidate, no matter how cheap the stock looks.

4. Clear undervaluation
The stock should trade at least 20-30% below your calculated intrinsic value. This gives you margin of safety and room for the stock to appreciate meaningfully within your LEAPS window.

Use discounted cash flow, earnings yield, or payback time models to estimate fair value. Simplify the process using Wall St Yardie to get a fair value calculation quickly.

5. Near-term catalyst
This is what separates LEAPS from stock ownership. You need a reason to believe the market will re-rate the stock within your timeframe. Catalysts might include:

• New product launch or service expansion
• Margin improvement from cost cuts
• Earnings inflection after temporary headwinds
• Industry tailwinds accelerating growth
• Pending spin-off or corporate action

Without a catalyst, you're just hoping the market wakes up. Hope is not a strategy.

6. Liquid options market
Check the bid-ask spread and open interest on the LEAPS contracts. If the spread is wide (say, $2 or more), you'll overpay to enter and lose value exiting. If open interest is low, liquidity dries up when you want to sell.

Stick to large-cap stocks with active options markets. This protects you from getting squeezed on entry and exit.

What to Avoid

Cyclical companies
Businesses tied to economic cycles, commodities, or seasonal demand make terrible LEAPS candidates. You might be right about the long-term value, but if the cycle turns against you during your 18-month window, you lose.

Examples: airlines, energy producers, homebuilders. These can be great stocks, but the timing risk is too high for LEAPS.

Turnaround stories
Companies trying to fix broken business models are high-risk, high-reward bets. LEAPS add leverage and time pressure to an already uncertain situation. One misstep and your option expires worthless.

If you love a turnaround story, buy the stock and hold it for three to five years. Don't try to time it with LEAPS.

High volatility, unpredictable earnings
Stocks with earnings that swing wildly or depend on one-off events (like biotech waiting for FDA approval) are speculation, not investing. LEAPS on these names are lottery tickets.

You want the opposite: stable, boring, predictable. Let the market undervalue predictability. That's your edge.

Dividend-heavy stocks
If the stock pays a large dividend, be cautious. Deep in-the-money LEAPS can be subject to early assignment around ex-dividend dates. You could get forced out of your position earlier than planned.

It's not a dealbreaker, but it's something to monitor if you're holding very deep ITM contracts.

For more on avoiding risky setups, see when NOT to use LEAPS.

Real World Example

Let's say you're screening for LEAPS candidates and find three stocks:

Stock A: Large-cap software company, recurring revenue, 30% free cash flow margin, zero debt, trading 25% below DCF fair value. Recent product upgrade cycle starting in six months.

Stock B: Mid-cap retailer, cyclical sales, 5% operating margin, high debt load, trading 40% below book value. No clear catalyst but "looks cheap."

Stock C: Small-cap biotech, binary outcome on drug approval in 12 months, no revenue yet, trading at cash value. High risk, high reward.

Which one gets the LEAPS?

Stock A checks every box: quality, predictability, clear undervaluation, and a catalyst. This is a textbook LEAPS candidate.

Stock B is a value trap. High debt and cyclical sales mean timing risk is huge. The discount doesn't matter if earnings collapse before your LEAPS expires.

Stock C is pure speculation. Binary outcomes don't belong in a value-based LEAPS strategy. If you want to gamble on biotech, buy shares or walk away.

What Could Go Wrong?

You pick a company with hidden weaknesses:
The business looks solid, but industry headwinds or management missteps emerge after you buy. Your LEAPS loses value even though the stock only drops modestly.

Mitigation: Stick to companies you deeply understand. Read earnings calls, check insider buying, and track industry trends before committing.

The catalyst gets delayed:
The product launch or margin improvement you're banking on takes longer than expected. Your LEAPS expires before the re-rating happens.

Mitigation: Add buffer time. If you think the catalyst is 12 months out, buy an 18- or 24-month LEAPS, not a 12-month.

Liquidity dries up:
You bought a LEAPS on a smaller company with thin options volume. When you try to exit, the bid-ask spread is brutal.

Mitigation: Only use LEAPS on large-cap, liquid names. Check open interest and daily volume before entering.

You confuse "cheap" with "quality":
The stock looks undervalued, but it's cheap for a reason. Weak fundamentals, declining industry, or poor management make it a bad LEAPS candidate.

Mitigation: Quality first, valuation second. Never compromise on business strength just to get a bigger discount.

You ignore the balance sheet:
The company has too much debt or weak cash flow. A downturn or refinancing issue tanks the stock and your LEAPS with it.

Mitigation: Run the numbers on debt ratios and free cash flow. If the balance sheet is weak, walk away.

Next Steps

• Build a watchlist of 10-15 high-quality companies with durable moats and strong balance sheets
• Screen for stocks trading 20-30% below intrinsic value using DCF, earnings yield, or payback time models
• Identify near-term catalysts: product launches, margin expansion, or industry tailwinds within the next 12-18 months
• Check options liquidity: look for tight bid-ask spreads and open interest above 100 contracts
• Run the stock through the value stock checklist before committing to a LEAPS position
• Use Wall St Yardie to quickly calculate fair value and confirm undervaluation

For the next step, learn how to select the right strike price and choose the right expiration to maximize your edge.